NeuroRestore is a research and innovation institution that develops and implements medical remedies to restore neurological functions.
NeuroRestore has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
NeuroRestore's investors include Michael J. Fox Foundation, Reeve Foundation.
NeuroRestore is headquartered in Vaud, Switzerland.
NeuroRestore is a research and innovation institution that develops and implements medical remedies to restore neurological functions.
NeuroRestore is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroRestore — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/neurorestore. Accessed September 30, 2026.
VCBacked. (2024). NeuroRestore — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neurorestore
{{cite web |title=NeuroRestore — Funding & Investors |url=https://www.vcbacked.co/company/neurorestore |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated